Structure Therapeutics Inc
NASDAQ:GPCR
Intrinsic Value
The intrinsic value of one GPCR stock under the Base Case scenario is 7.15 USD. Compared to the current market price of 56.15 USD, Structure Therapeutics Inc is Overvalued by 87%.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Structure Therapeutics Inc.
The intrinsic value of one GPCR stock under the Base Case scenario is 7.15 USD.
Compared to the current market price of 56.15 USD, Structure Therapeutics Inc is Overvalued by 87%.